Jia Yong, Quinn Christopher M, Kwak Silvia, Talanian Robert V
Abbott Laboratories, 100 Research Drive, Worcester, MA 01605, USA.
Curr Drug Discov Technol. 2008 Mar;5(1):59-69. doi: 10.2174/157016308783769414.
The rapidly growing interest in kinases as drug targets has prompted the development of many kinase assay technologies. These technologies can be grouped into three categories: radiometric assays, phospho-antibody-dependent fluorescence/luminescence assays, and phospho-antibody-independent fluorescence/luminescence assays. This article will review some of the major kinase assay technologies on the market, with particular emphasis on the newest systems. We will describe the physical principles, the practical advantages and drawbacks, and the potential applications of these technologies in kinase drug discovery. Most of these technologies are suitable for HTS, but only a few can be utilized for kinetic and mechanistic studies. Significant progress towards development of generic assays, free of radioisotopes and custom reagents such as phospho-specific antibodies, has been made in recent years. However, due to various limitations of each format, none of these generic assay technologies can yet claim to be truly universal. Several factors, including the intended applications, cost, timeline, expertise, familiarity, and comfort level, should be considered prior to pursuing a particular kinase assay technology.
激酶作为药物靶点的兴趣迅速增长,促使了许多激酶检测技术的发展。这些技术可分为三类:放射性检测、依赖磷酸化抗体的荧光/发光检测以及不依赖磷酸化抗体的荧光/发光检测。本文将综述市场上一些主要的激酶检测技术,特别强调最新的系统。我们将描述这些技术的物理原理、实际优缺点以及它们在激酶药物发现中的潜在应用。这些技术大多适用于高通量筛选(HTS),但只有少数可用于动力学和机制研究。近年来,在开发不含放射性同位素和磷酸化特异性抗体等定制试剂的通用检测方法方面取得了重大进展。然而,由于每种形式都有各种局限性,这些通用检测技术中尚无一种能声称是真正通用的。在采用特定的激酶检测技术之前,应考虑几个因素,包括预期应用、成本、时间安排、专业知识、熟悉程度和舒适度。